Irvine, CA, United States of America

Jeffrey P Dumontelle

This inventor holds 20 USPTO granted patents and 9 published patent applications and 7 EPO patents, primarily in Cardiac Devices. Top assignees: Valcare, Inc., Medtronic 3F Therapeutics, Inc., Micardia Corporation. Active years: 2003-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeffrey P Dumontelle. Retrieved from https://idiyas.com/inventor/jeffrey-p-dumontelle

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 

% Patents Active = 90.0

 

Average Co-Inventor Count = 3.3

ph-index = 6

Forward Citations = 177(Granted Patents)


Company Filing History:


Years Active: 2003-2024

Loading Chart...
Loading Chart...
Areas of Expertise:
Annuloplasty System
Valve Replacement
Bio-Prosthesis
Tissue Anchoring
Surgical Instrument
Cardiac Delivery
Adjustable Ring
Percutaneous Methods
Support Structure
Implantable Valve
Vascular Devices
Surgical Techniques
20 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Jeffrey P. Dumontelle in Heart Valve Technology**

Introduction

Jeffrey P. Dumontelle, based in Irvine, CA, is a distinguished inventor holding an impressive portfolio of 20 patents. His innovations primarily focus on advanced medical technologies, particularly in the field of heart valve repair. Dumontelle's contributions have significantly impacted the landscape of cardiology through innovative devices and systems that enhance patient outcomes.

Latest Patents

Dumontelle's latest patents showcase his expertise and creativity. One such invention is a **percutaneous annuloplasty system with anterior-posterior adjustment.** This groundbreaking apparatus provides methods for repairing heart valves via the percutaneous transcatheter delivery and fixation of annuloplasty rings. The design incorporates an outer hollow body member with multiple regions that can transition from an elongated insertion geometry to an annular operable geometry. This flexibility is achieved through a biasing element or a stepped connector, allowing the annuloplasty ring to adapt to the heart valve's needs effectively.

Another notable invention is a **device, system, and method to secure an article to a tissue.** This innovative device features a body that can transition from a deployment state to a securing state. The design includes a first and second portion, both equipped with ends that can pierce tissue. In the securing state, the device anchors the article to the tissue, demonstrating Dumontelle's ability to create solutions that seamlessly integrate with biological structures.

Career Highlights

Throughout his career, Dumontelle has been associated with reputable companies such as Valcare, Inc. and Medtronic 3F Therapeutics, Inc. His work in these organizations has allowed him to develop pioneering technologies that bridge the gap between engineering and medicine. Dumontelle’s contributions have not only advanced technical knowledge but also enhanced the efficacy of heart surgeries, improving the quality of life for many patients.

Collaborations

Dumontelle has collaborated with talented individuals including Samuel M. Shaolian and Nadav Yellin. These partnerships have fostered a dynamic environment for innovation, where shared expertise leads to the development of cutting-edge solutions in heart valve technology.

Conclusion

Jeffrey P. Dumontelle’s inventive spirit and dedication to improving medical devices have positioned him as a leading figure in the field of cardiology. His 20 patents reflect his commitment to technological advancement and patient care. As medical technology continues to evolve, Dumontelle’s contributions will undoubtedly play a crucial role in shaping future innovations in heart valve repair and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…